GLENMARK - Investment Analysis: Buy Signal or Bull Trap?
Back to ListInvestment Rating: 3.5
| Stock Code | GLENMARK | Market Cap | 68,635 Cr. | Current Price | 2,431 ₹ | High / Low | 2,474 ₹ |
| Stock P/E | 46.3 | Book Value | 848 ₹ | Dividend Yield | 0.10 % | ROCE | 9.72 % |
| ROE | 7.35 % | Face Value | 1.00 ₹ | DMA 50 | 2,198 ₹ | DMA 200 | 1,996 ₹ |
| Chg in FII Hold | 1.15 % | Chg in DII Hold | -0.81 % | PAT Qtr | 426 Cr. | PAT Prev Qtr | 193 Cr. |
| RSI | 70.3 | MACD | 71.2 | Volume | 9,38,136 | Avg Vol 1Wk | 7,18,504 |
| Low price | 1,355 ₹ | High price | 2,474 ₹ | PEG Ratio | 23.1 | Debt to equity | 0.02 |
| 52w Index | 96.2 % | Qtr Profit Var | 3.00 % | EPS | 0.74 ₹ | Industry PE | 30.9 |
📊 Glenmark shows weak profitability metrics with ROCE at 9.72% and ROE at 7.35%, which are below industry standards. The company is nearly debt-free (0.02 debt-to-equity), ensuring financial stability. However, the P/E of 46.3 is significantly higher than the industry average of 30.9, making it expensive. The PEG ratio of 23.1 further highlights overvaluation relative to growth. Current price ₹2,431 is near its 52-week high (₹2,474), suggesting limited upside potential. RSI at 70.3 indicates overbought conditions, while MACD at 71.2 shows strong momentum. Quarterly PAT growth is modest at 3%, despite a sharp jump in EPS being very low (₹0.74), raising concerns about sustainability.
💡 Ideal Entry Zone: ₹2,000 – ₹2,150 (closer to 200 DMA support).
📈 Exit Strategy: Investors already holding should consider short-to-medium term (1–2 years) horizon. Partial profit booking is advisable near ₹2,450–₹2,470 resistance levels. Long-term holding is risky given weak ROE, ROCE, and stretched valuations.
Positive
- Debt-to-equity ratio of 0.02 ensures financial stability.
- Strong momentum with RSI 70.3 and MACD 71.2.
- Quarterly PAT improved from ₹193 Cr. to ₹426 Cr.
- FII holdings increased (+1.15%), showing foreign investor confidence.
Limitation
- Low ROE (7.35%) and ROCE (9.72%) compared to peers.
- High P/E (46.3) relative to industry average (30.9).
- PEG ratio of 23.1 indicates severe overvaluation.
- DII holdings decreased (-0.81%), showing reduced domestic support.
Company Negative News
- No major negative news reported, but weak profitability metrics remain a concern.
Company Positive News
- Quarterly PAT growth shows operational improvement.
- FII stake increased, reflecting foreign investor interest.
Industry
- Pharmaceutical sector remains resilient with long-term demand drivers.
- Industry P/E of 30.9 reflects moderate optimism in healthcare stocks.
Conclusion
⚠️ Glenmark is financially stable but has weak profitability and stretched valuations. The stock is trading near its 52-week high, limiting upside potential. Ideal entry is near ₹2,000–₹2,150. Existing investors should consider partial profit booking near resistance levels and avoid long-term holding unless profitability improves significantly.